Cerus (CERS) EBIT (QoQ) (2010 - 2026)
Cerus (CERS) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.77% |
| Dec 31, 2025 | -151.86% |
| Sep 30, 2025 | 136.11% |
| Jun 30, 2025 | 41.52% |
| Mar 31, 2025 | -303.93% |
| Dec 31, 2024 | -50.78% |
| Sep 30, 2024 | 74.95% |
| Jun 30, 2024 | 51.92% |
| Mar 31, 2024 | -917.52% |
| Dec 31, 2023 | 118.62% |
| Sep 30, 2023 | 54.96% |
| Jun 30, 2023 | 17.72% |
| Mar 31, 2023 | -42.16% |
| Dec 31, 2022 | -33.62% |
| Sep 30, 2022 | -8.95% |
| Jun 30, 2022 | 30.60% |
| Mar 31, 2022 | -41.45% |
| Dec 31, 2021 | 37.43% |
| Sep 30, 2021 | 22.74% |
| Jun 30, 2021 | 12.44% |